Interestingly, IL-12, a potent promoter of IFN-γ production, is reported to be lowered in ATB-T2DM patients and impairs the ability of Th1 cells to produce sufficient IFN-γ levels to control Mtb infection (85). Here, IFNG is linked to type 2 diabetes mellitus.